CDC Logo Tuberculosis Information CD-ROM   Image of people
     
jump over main navigation bar to content area
Home
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Newsletters
Ordering Information
Help

 

U.S. Department of Health and Human Services

  

This is an archived document. The links are no longer being updated.

TB Notes 4, 2003

NEW CDC PUBLICATIONS

Adatu F, Odeke R, Mugenyi M, Gargioni G, McCray E, Schneider E, and Maher D. Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis 2003 Sep; 7(9, Suppl 1): S63-S71.

American Academy of Pediatrics, Committee on Infectious Diseases. Pickering LK, ed. Tuberculosis. In:  2003 Red Book: Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003.

American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America.  Treatment of Tuberculosis Power Point Slide Set.  2003.

CDC.  Tuberculosis Education and Training Resource Guide. 2003.

Filliol I, Driscoll JR, Van Soolingen D, et al. Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol 2003 May; 41(5): 1963-1970.

Frieden TR and Driver CR. Tuberculosis control: past 10 years and future progress. Tuberculosis 2003: 93(1-3): 82-85.

Frieden TR and Khatri GR. Impact of national consultants on successful expansion of effective tuberculosis control in India. Int J Tuberc Lung Dis 2003 Sep; 7(9): 837-841.

Frieden T R, Sterling T R, Munsiff S S, Watt C J, and Dye C. Tuberculosis.  Lancet  2003 Sep 13; 362 (9387): 887-899.

Kherosheva T, Thorpe L E, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, and Kazionny B. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. International Journal of Tuberculosis and Lung Disease  2003 Nov; 7(11): 1045-1051.

Kim D Y, Ridzon R, Giles B, Mireles T, Garrity K, Hathcock A L, Crowder D, Jackson R, and Taylor Z. A no-name tuberculosis tracking system. American Journal of Public Health 2003 Oct; 93(10): 1637-1639.

Kwara A, Schiro R, Cowan LS, et al. Evaluation of the epidemiologic utility of secondary typing methods for differentiation of Mycobacterium tuberculosis isolates. J Clin Microbiol 2003 Jun; 41(6): 2683-2685.

Li JH, Driver CR, Munsiff SS, Yip R, and Fujiwara PI. Differential decline in tuberculosis incidence among US- and non-US-born persons in New York City. Int J Tuberc Lung Dis 2003 May; 7(5): 451-457.

LoBue P A and Moser K S. Use of isoniazid for latent tuberculosis infection in a public health clinic. American Journal of Respiratory and Critical Care Medicine 2003 Aug 15; 168(4): 443-447.

Lockman S, Hone N, Kenyon TA, et al. Etiology of pulmonary infections in predominantly HIV-infected adults with suspected tuberculosis, Botswana. Int J Tuberc Lung Dis 2003 Aug; 7(8): 714-723.

Martinez-Guarneros A, Balandrano-Campos S, Solano-Ceh MA, et al. Implementation of proficiency testing in conjunction with a rechecking system for external quality assurance in tuberculosis laboratories in Mexico. Int J Tuberc Lung Dis 2003 Jun; 7(6): 516-521.

McLaughlin SI, Spradling P, Drociuk D, Ridzon R, Pozsik CJ, and Onorato I. Extensive transmission of Mycobacterium tuberculosis among congregated, HIV-infected prison inmates in South Carolina, United States. Int J Tuberc Lung Dis 2003 Jul; 7(7): 665-672.

Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, and Kenyon T. Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana. Int J Tuberc Lung Dis 2003 Sep; 7(9, Suppl 1): S80-S85.

Morozova I, Riekstina V, Sture G, Wells C, and Leimane V. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Int J Tuberc Lung Dis 2003 Sep; 7(9): 903-906.

Mosimaneotsile B, Talbot E A, Moeti T L, Hone N M, Moalosi G, Moffat H J, Lee E J, and Kenyon T A. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003 Nov 8; 362 (9395): 1551-2.

Radhakrishna S, Frieden T R, and Subramani R. Association of initial tuberculin sensitivity, age, and sex with the incidence of tuberculosis in South India: a 15-year follow-up. International Journal of Tuberculosis and Lung Disease 2003 Nov; 7(11): 1083-1091.

Reichard AA, Lobato MN, Roberts CA, Bazerman LB, Hammett TM.  Assessment of tuberculosis screening and management practices of large jail systems. Public Health Reports 2003 Nov-Dec;118(6): 500-507.

Schneider E and Castro KG. Tuberculosis trends in the United States, 1992-2001. Tuberculosis 2003; 83(1-3): 21-29.

Silva M S, Senna S G, Ribeiro M O, Valim A R, Telles M A, Kritski A, Morlock G P, Cooksey R C, Zaha A, and Rossetti M L. Mutations in KatG, InhA, and AhpC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. Journal of Clinical Microbiology  2003 Sep; 41 (9): 4471-4474.

Talbot EA, Hone NM, Moffat HJ, et al. The validity of HIV testing using sputum from suspected tuberculosis patients, Botswana, 2001. Int J Tuberc Lung Dis 2003 Aug; 7(8): 710-713.

Talbot EA, Kenyon TA, Mwasekaga MJ, Moeti TL, Mallon V, and Binkin NJ. Control of anti-tuberculosis drug resistance in Botswana. Int J Tuberc Lung Dis 2003 Jan; 7(1): 72-77.

Uthaivoravit W, Yanai H, Tappero JW, et al. Impact of enhanced notification of tuberculosis laboratory results to minimise treatment delay, Chiang Rai Hospital, Northern Thailand. Int J Tuberc Lung Dis 2003 Jan; 7(1): 46-51.

Weiner M, Burman W, Vernon A, et al. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J Respir Crit Care Med 2003 May 15; 167(10): 1341-1347.

White MC, Gournis E, Kawamura M, Menendez E, and Tulsky JP. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. Int J Tuberc Lung Dis 2003 Jan; 7(1): 30-35.

 


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb

Please send comments/suggestions/requests to: hsttbwebteam@cdc.gov, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333